Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases

JAMA. 2018 Apr 10;319(14):1431-1432. doi: 10.1001/jama.2018.0345.

Authors

Barney S Graham¹, John R Mascola¹, Anthony S Fauci²

Affiliations

¹ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
² Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

PMID: 29566112
DOI: 10.1001/jama.2018.0345

No abstract available

MeSH terms

Communicable Diseases, Emerging / prevention & control*
DNA, Viral
Epidemics / prevention & control
Humans
Plasmids
Time Factors
Vaccines, Synthetic
Viral Vaccines*
Virus Diseases / epidemiology
Virus Diseases / prevention & control*

Substances

DNA, Viral
Vaccines, Synthetic
Viral Vaccines